Literature DB >> 17544493

Pneumococcal conjugate vaccine is immunogenic in lung fluid of HIV-infected and immunocompetent adults.

Stephen B Gordon, Helena Kayhty, Malcolm E Molyneux, Raili Haikala, Anu Nurkka, Janelisa Musaya, Eduard E Zijlstra, Dennis Lindell, Neil French.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17544493      PMCID： PMC5063094          DOI： 10.1016/j.jaci.2007.03.050

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  10 in total

Review 1.  Impact of conjugate pneumococcal vaccines.

Authors:  Cynthia G Whitney
Journal:  Pediatr Infect Dis J       Date:  2005-08       Impact factor: 2.129

2.  Prior pneumococcal vaccination is associated with reduced death, complications, and length of stay among hospitalized adults with community-acquired pneumonia.

Authors:  David N Fisman; Elias Abrutyn; Kimberly A Spaude; Alex Kim; Cheryl Kirchner; Jennifer Daley
Journal:  Clin Infect Dis       Date:  2006-03-13       Impact factor: 9.079

3.  Acute phase reaction in healthy volunteers after bronchoscopy with lavage.

Authors:  Yuh-Chin T Huang; Mary Ann Bassett; Debra Levin; Tracy Montilla; Andrew J Ghio
Journal:  Chest       Date:  2006-06       Impact factor: 9.410

Review 4.  Mucosal immunity induced by pneumococcal glycoconjugate.

Authors:  Chi-Jen Lee; Lucia H Lee; Xin-Xing Gu
Journal:  Crit Rev Microbiol       Date:  2005       Impact factor: 7.624

5.  Combined treatment with surfactant and specific immunoglobulin reduces bacterial proliferation in experimental neonatal group B streptococcal pneumonia.

Authors:  E Herting; X Gan; P Rauprich; C Jarstrand; B Robertson
Journal:  Am J Respir Crit Care Med       Date:  1999-06       Impact factor: 21.405

6.  Intracellular trafficking and killing of Streptococcus pneumoniae by human alveolar macrophages are influenced by opsonins.

Authors:  S B Gordon; G R Irving; R A Lawson; M E Lee; R C Read
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

7.  Emergence of antibody to capsular polysaccharides of Streptococcus pneumoniae during outbreaks of pneumonia: association with nasopharyngeal colonization.

Authors:  D M Musher; J E Groover; M R Reichler; F X Riedo; B Schwartz; D A Watson; R E Baughn; R F Breiman
Journal:  Clin Infect Dis       Date:  1997-03       Impact factor: 9.079

8.  Conjugate pneumococcal vaccine in HIV-infected Ugandans and the effect of past receipt of polysaccharide vaccine.

Authors:  George Miiro; Helena Kayhty; Christine Watera; Helen Tolmie; James A G Whitworth; Charles F Gilks; Neil French
Journal:  J Infect Dis       Date:  2005-10-05       Impact factor: 5.226

9.  Pulmonary immunoglobulin responses to Streptococcus pneumoniae are altered but not reduced in human immunodeficiency virus-infected Malawian adults.

Authors:  Stephen B Gordon; David E Miller; Richard B Day; Tom Ferry; David S Wilkes; Carol T Schnizlein-Bick; Eduard E Zijlstra; Robert C Read; Malcolm E Molyneux; Homer L Twigg
Journal:  J Infect Dis       Date:  2003-08-20       Impact factor: 5.226

Review 10.  Bacterial pneumonia vaccines and childhood pneumonia: are we winning, refining, or redefining?

Authors:  Stephen K Obaro; Shabir A Madhi
Journal:  Lancet Infect Dis       Date:  2006-03       Impact factor: 25.071
  10 in total
  7 in total

1.  A trial of a 7-valent pneumococcal conjugate vaccine in HIV-infected adults.

Authors:  Neil French; Stephen B Gordon; Thandie Mwalukomo; Sarah A White; Gershom Mwafulirwa; Herbert Longwe; Martin Mwaiponya; Eduard E Zijlstra; Malcolm E Molyneux; Charles F Gilks
Journal:  Malawi Med J       Date:  2016-09       Impact factor: 0.875

2.  Quantitative and Functional Antibody Responses to the 13-Valent Conjugate and/or 23-Valent Purified Polysaccharide Vaccine in Aging HIV-Infected Adults.

Authors:  Jennifer A Ohtola; Jessica L Saul-McBeth; Anita S Iyer; David J Leggat; Sadik A Khuder; Noor M Khaskhely; Ma Julie Westerink
Journal:  J AIDS Clin Res       Date:  2016-03-14

3.  A trial of a 7-valent pneumococcal conjugate vaccine in HIV-infected adults.

Authors:  Neil French; Stephen B Gordon; Thandie Mwalukomo; Sarah A White; Gershom Mwafulirwa; Herbert Longwe; Martin Mwaiponya; Eduard E Zijlstra; Malcolm E Molyneux; Charles F Gilks
Journal:  N Engl J Med       Date:  2010-03-04       Impact factor: 91.245

4.  The alveolar microenvironment of patients infected with human immunodeficiency virus does not modify alveolar macrophage interactions with Streptococcus pneumoniae.

Authors:  Stephen B Gordon; R Thomas Jagoe; Elizabeth R Jarman; James C North; Alison Pridmore; Janelisa Musaya; Neil French; Eduard E Zijlstra; Malcolm E Molyneux; Robert C Read
Journal:  Clin Vaccine Immunol       Date:  2013-04-10

Review 5.  Safety, immunogenicity and efficacy of pneumococcal conjugate vaccine in HIV-infected individuals.

Authors:  Marta C Nunes; Shabir A Madhi
Journal:  Hum Vaccin Immunother       Date:  2012-02-01       Impact factor: 3.452

6.  Inhaled delivery of 23-valent pneumococcal polysaccharide vaccine does not result in enhanced pulmonary mucosal immunoglobulin responses.

Authors:  Stephen B Gordon; Rose Malamba; Neema Mthunthama; Elizabeth R Jarman; Kondwani Jambo; Khuzwayo Jere; Eduard E Zijlstra; Malcolm E Molyneux; John Dennis; Neil French
Journal:  Vaccine       Date:  2008-08-15       Impact factor: 3.641

7.  Long-term immune responses and comparative effectiveness of one or two doses of 7-valent pneumococcal conjugate vaccine (PCV7) in HIV-positive adults in the era of combination antiretroviral therapy.

Authors:  Aristine Cheng; Sui-Yuan Chang; Mao-Song Tsai; Yi-Ching Su; Wen-Chun Liu; Hsin-Yun Sun; Chien-Ching Hung
Journal:  J Int AIDS Soc       Date:  2016-01-29       Impact factor: 5.396
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.